Insilico Medicine

AI-first drug design built on AlphaFold for pharma R&D.

Isomorphic Labs is an AI-first drug discovery company spun out of Google DeepMind, building generative and predictive ML models for molecular design and drug-performance prediction. Its Drug Design Engine builds on AlphaFold to advance internal and partnered pipelines with Eli Lilly, Novartis, and J&J. It is a drug-discovery company that works through pharma R&D partnerships rather than a self-serve product.

AI-driven drug discovery on the Recursion OS platform.

Recursion is a clinical-stage, technology-enabled drug discovery company built around Recursion OS, which pairs one of biopharma's largest proprietary datasets with automated wet labs and machine learning for target and molecule discovery. Its LOWE interface lets scientists query the platform in natural language to find targets, generate compounds, and schedule experiments. It advances an internal pipeline and partners with pharma rather than selling self-serve software.

Foundation models for molecular structure and antibody design.

Chai Discovery builds foundation models for drug discovery — Chai-1 for biomolecular structure prediction across proteins, ligands, DNA/RNA, and glycans, and Chai-2 for de novo antibody design. Chai-1 weights and inference code are released for non-commercial use, and a free web server runs the model in-browser. It is both a model provider and a usable platform.

AI protein-engineering platform for faster lab design rounds.

Cradle is an AI-powered protein-engineering SaaS platform that guides scientists through design rounds — candidate generation, multi-property optimization, and results analysis — using ML models trained per-customer on proprietary wet-lab data. It runs its own validation wet lab in Amsterdam and serves biopharma and industrial-biotech R&D teams including Novo Nordisk and Johnson & Johnson. It is sold via subscription with no royalties, and customers keep full IP.